165 related articles for article (PubMed ID: 17973255)
1. RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells.
Roesch A; Mueller AM; Stempfl T; Moehle C; Landthaler M; Vogt T
Int J Cancer; 2008 Mar; 122(5):1047-57. PubMed ID: 17973255
[TBL] [Abstract][Full Text] [Related]
2. Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells.
Roesch A; Becker B; Schneider-Brachert W; Hagen I; Landthaler M; Vogt T
J Invest Dermatol; 2006 Aug; 126(8):1850-9. PubMed ID: 16645588
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of RBP2-H1 variant of JARID1B in melanoma.
Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW
BMC Cancer; 2017 Dec; 17(1):854. PubMed ID: 29246117
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of the transcription repressor PLU-1/JARID1B.
Scibetta AG; Santangelo S; Coleman J; Hall D; Chaplin T; Copier J; Catchpole S; Burchell J; Taylor-Papadimitriou J
Mol Cell Biol; 2007 Oct; 27(20):7220-35. PubMed ID: 17709396
[TBL] [Abstract][Full Text] [Related]
5. Altered Splicing of JARID1B in Development of Human Cutaneous Melanoma?
Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW
Appl Immunohistochem Mol Morphol; 2016 Mar; 24(3):188-92. PubMed ID: 25789538
[TBL] [Abstract][Full Text] [Related]
6. Histone demethylase JARID1B promotes cell proliferation but is downregulated by N-Myc oncoprotein.
Zhang L; Sokolowski N; Atmadibrata B; Liu T
Oncol Rep; 2014 Apr; 31(4):1935-9. PubMed ID: 24481781
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of a novel retinoblastoma binding protein 2-homolog is a consistent feature of sporadic human melanoma skin cancer.
Vogt T; Kroiss M; McClelland M; Gruss C; Becker B; Bosserhoff AK; Rumpler G; Bogenrieder T; Landthaler M; Stolz W
Lab Invest; 1999 Dec; 79(12):1615-27. PubMed ID: 10616211
[TBL] [Abstract][Full Text] [Related]
8. Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas.
Roesch A; Becker B; Meyer S; Wild P; Hafner C; Landthaler M; Vogt T
Mod Pathol; 2005 Sep; 18(9):1249-57. PubMed ID: 15803180
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases.
Barrett A; Santangelo S; Tan K; Catchpole S; Roberts K; Spencer-Dene B; Hall D; Scibetta A; Burchell J; Verdin E; Freemont P; Taylor-Papadimitriou J
Int J Cancer; 2007 Jul; 121(2):265-75. PubMed ID: 17373667
[TBL] [Abstract][Full Text] [Related]
10. JARID1B expression in human melanoma and benign melanocytic skin lesions.
Kuźbicki L; Lange D; Strączyńska-Niemiec A; Chwirot BW
Melanoma Res; 2013 Feb; 23(1):8-12. PubMed ID: 23262439
[TBL] [Abstract][Full Text] [Related]
11. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.
Roesch A; Fukunaga-Kalabis M; Schmidt EC; Zabierowski SE; Brafford PA; Vultur A; Basu D; Gimotty P; Vogt T; Herlyn M
Cell; 2010 May; 141(4):583-94. PubMed ID: 20478252
[TBL] [Abstract][Full Text] [Related]
12. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3.
Christensen J; Agger K; Cloos PA; Pasini D; Rose S; Sennels L; Rappsilber J; Hansen KH; Salcini AE; Helin K
Cell; 2007 Mar; 128(6):1063-76. PubMed ID: 17320161
[TBL] [Abstract][Full Text] [Related]
13. JARID1B protein expression and prognostic implications in uveal melanoma.
Radberger P; Radberger A; Bykov VJ; Seregard S; Economou MA
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4442-9. PubMed ID: 22669717
[TBL] [Abstract][Full Text] [Related]
14. A role for the JARID1B stem cell marker for continuous melanoma growth.
Held M; Bosenberg M
Pigment Cell Melanoma Res; 2010 Aug; 23(4):481-3. PubMed ID: 20546534
[No Abstract] [Full Text] [Related]
15. The PcG protein hPc2 interacts with the N-terminus of histone demethylase JARID1B and acts as a transcriptional co-repressor.
Zhou W; Chen H; Zhang L
BMB Rep; 2009 Mar; 42(3):154-9. PubMed ID: 19336002
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.
Wang H; Song C; Ding Y; Pan X; Ge Z; Tan BH; Gowda C; Sachdev M; Muthusami S; Ouyang H; Lai L; Francis OL; Morris CL; Abdel-Azim H; Dorsam G; Xiang M; Payne KJ; Dovat S
J Biol Chem; 2016 Feb; 291(8):4004-18. PubMed ID: 26655717
[TBL] [Abstract][Full Text] [Related]
17. Jarid1b promotes epidermal differentiation by mediating the repression of Ship1 and activation of the AKT/Ovol1 pathway.
Sun X; Li Z; Niu Y; Zhao L; Huang Y; Li Q; Zhang S; Chen T; Fu T; Yang T; An X; Jiang Y; Zhang J
Cell Prolif; 2019 Sep; 52(5):e12638. PubMed ID: 31152465
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Regulation of Angiogenesis by JARID1B-Induced Repression of HOXA5.
Fork C; Gu L; Hitzel J; Josipovic I; Hu J; SzeKa Wong M; Ponomareva Y; Albert M; Schmitz SU; Uchida S; Fleming I; Helin K; Steinhilber D; Leisegang MS; Brandes RP
Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1645-52. PubMed ID: 26023081
[TBL] [Abstract][Full Text] [Related]
19. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y
Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of JARID1B promotes differentiation via SHIP1/AKT signaling in human hypopharyngeal squamous cell carcinoma.
Zhang J; An X; Han Y; Ma R; Yang K; Zhang L; Chi J; Li W; Llobet-Navas D; Xu Y; Jiang Y
Cell Death Dis; 2016 Sep; 7(9):e2358. PubMed ID: 27584795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
